Corporate Social Responsibility
Ethical Code
Kymos is a group with the highest ethical standards. To this end, we have formulated an Ethical Code that is binding for all employees, shareholders, management bodies, and all members of Kymos and its subsidiaries.
Kymos has also subscribed to a Code of Talent based on the good practices designed by EJE&CON, an association of executive women, to guarantee equality of treatment and promotion of women to executive positions
Kymos has also designed an Equality Plan and conducted an impact assessment of procedures and practices to avoid gender bias and designed a set of actions meant to guarantee equality of treatment and opportunities between men and women. You can read more in the specific section.
Due to the nature of our activities, we also have a Work Risk & Prevention plan, SOP-regulated Environment, Health and Safety policies, as well as a continuous commitment to the improvement of sustainable development, reduction of energy consumption, and corporate social responsibility.
For over 10 years, Prolytic has been committed to helping the disadvantaged of this world with two child sponsorships with World Vision. With a child sponsorship, we give a needy child in one of the poorest countries in the world a better future. By sponsoring a child, the child’s life is changed in a lasting way. Lasting improvements in the lives of needy children are only possible if their environment is changed. The help of a World Vision sponsorship is therefore not limited to the sponsored child – the child’s family and region are also involved.
Kymos as a group commits and takes full responsibility regarding its activity and its impact on society. We believe that every company should have a positive role in the community and we consider it necessary to take into account the social and environmental impact in all our business decisions and operations.
Taking that into consideration, we have collaborated with Respon.cat, the organization of reference in CSR (Corporate Social Responsibility) in Catalonia, towards building our own CSR plan with our adherence to their program RSE.Pime 2022-2023.
RSE.Pime is a practical program aimed at implementing CSR in Catalan companies with the support of the Departament de Treball i Empresa, and in collaboration with the Consell de Cambres de Catalunya and the Cambra de Comerç de Barcelona. As a result of this program, we have developed our Good Practices Document with Respon.cat.
Kymos stands for the equality of treatment and opportunities between men and women. To guarantee it, we have designed an Equality Plan revised by the Equality Commission of the company and registered in the Departament d’Empresa i Treball from Generalitat de Catalunya.
The plan contains a set of ordered measures, adopted after conducting a situation diagnosis, aimed at achieving equal treatment and opportunities for men and women in the company and eliminating discrimination based on gender.
Key actions include:
• Regularly surveying employees on equality and improving based on feedback.
• Promoting equal opportunities in hiring and training staff on gender equity.
• Ensuring equal pay through a gender-sensitive job evaluation system and annual pay register.
• Assessing work-life balance needs, implementing feasible actions, and informing staff about leave options.
• Creating a gender-sensitive psychosocial risk survey.
• Updating the harassment prevention protocol and including it in corporate documents.
• Developing a protocol against gender violence and informing individuals of their rights.
KOREA PHARM & BIO: Goyang, KR | 23-26 Apr 2024
BIO KOREA 2024: Seoul, KR | 08-10 May 2024
BIO International Convention: San Diego, US | 3-6 Jun 2024
Congrès POLEPHARMA Biotesting: Évreux, FR | 5-6 Jun 2024
AFI Symposium: Rimini, IT | 5-7 Jun 2024
BIOPLUS – INTERPHEX KOREA: Seoul, KR | 10-12 Jul 2024
Farmaforum: Madrid, ES | 25-26 Sep 2024
Biomarkers Europe 2024: Basel, CH | 30 Sep – 01 Oct 2024
CPHI 2024: Milan, IT | 8-10 Oct 2024
BIO-Europe Autumn: Stockholm, SE | 4-6 Nov 2024
European Bioanalysis Forum: Barcelona, ES | 20-22 Nov 2024
PharmaLab Congress: Düsseldorf, DE | 25-27 Nov 2024
I4ID 2024: Lyon, FR | 27-28 Nov 2024
